Cargando…
Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets
Targeted therapy based on adjustment of microRNA (miRNA)s activity takes great promise due to the ability of these small RNAs to modulate cellular behavior. However, the efficacy of miR-101 replacement therapy to hepatocellular carcinoma (HCC) remains unclear. In the current study, we first observed...
Autores principales: | Zheng, Fang, Liao, Yi-Ji, Cai, Mu-Yan, Liu, Tian-Hao, Chen, Shu-Peng, Wu, Pei-Hong, Wu, Long, Bian, Xiu-Wu, Guan, Xin-Yuan, Zeng, Yi-Xin, Yuan, Yun-Fei, Kung, Hsiang-Fu, Xie, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334495/ https://www.ncbi.nlm.nih.gov/pubmed/25693145 http://dx.doi.org/10.1371/journal.pgen.1004873 |
Ejemplares similares
-
Correction: Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets
por: Zheng, Fang, et al.
Publicado: (2021) -
Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma
por: FU, YU, et al.
Publicado: (2013) -
Drug Nanorod-Mediated Intracellular Delivery of microRNA-101 for Self-sensitization via Autophagy Inhibition
por: Xin, Xiaofei, et al.
Publicado: (2019) -
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma
por: Vella, Serena, et al.
Publicado: (2015) -
Fine-tuning of microRNA-mediated repression of mRNA by splicing-regulated and highly repressive microRNA recognition element
por: Wu, Cheng-Tao, et al.
Publicado: (2013)